Brief: Quince Therapeutics Announces Pricing Of Up To $22 Mln Private Placement Of Securities
June 12 (Reuters) - Quince Therapeutics Inc QNCX.O: QUINCE THERAPEUTICS ANNOUNCES PRICING OF UP TO $22 MILLION PRIVATE PLACEMENT OF SECURITIES QUINCE THERAPEUTICS INC - FINANCING TO PROVIDE $11.5 MILLION UPFRONT, $10.4 MILLION FROM WARRANTS QUINCE THERAPEUTICS INC - PROCEEDS TO FUND PHASE 3 NEAT TRIAL AND CORPORATE PURPOSES QUINCE THERAPEUTICS INC - PROCEEDS EXPECTED TO FUND OPERATIONS INTO SECOND QUARTER 2026 Source text: ID:nBw4Lyg3Wa Further company coverage: QNCX.O (((( Reuters.briefs@thomsonreuters.com ;));))
Recent news on IRulya Therapeutics
See all newsBrief: Quince Therapeutics - Changes Name To Irulya Therapeutics
Brief: Quince Therapeutics - Appoints Brigette Roberts As CEO Effective October 8, 2026
Quince Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Quince Therapeutics Reports Second Quarter 2026 Financial Results And Corporate Update
Quince Therapeutics Q2 net loss widens on acquisition charges